Prokidney reports full year 2023 financial results and recent corporate highlights

Winston-salem, n.c., march 21, 2024 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (ckd), today announced financial results for the year ended december 31, 2023.

PROK Ratings Summary

PROK Quant Ranking